4 results on '"Frangiamore R."'
Search Results
2. Development and validation of the Myasthenia Gravis TeleScore (MGTS).
- Author
-
Pasqualin F, Guidoni SV, Albertini E, Ermani M, Frangiamore R, Vanoli F, Antozzi C, Mantegazza R, and Bonifati DM
- Subjects
- Female, Humans, Male, Pandemics, Reproducibility of Results, COVID-19, Myasthenia Gravis diagnosis
- Abstract
Objective: The aim of our study was to validate the Myasthenia Gravis TeleScore (MGTS), a scale for the evaluation of MG patients in telemedicine., Introduction: COVID-19 pandemic has boosted telemedicine in clinical practice. It could be crucial in the care of neurological patients with chronic disease. However, there is a lack of validated disease-specific tools to evaluate MG patients in telemedicine., Methods: The MGTS included ten items divided in four districts: ocular, generalized muscular strength, bulbar, and respiratory. Patients were assessed with two different scales: the MGTS and the INCB-MG chosen as a reference from which MGTS was partially derived. Visit in presence with INCB-MG and televisit with MGTS were performed consecutively. Televisit was conducted by another neurologist between two rooms. A blind method was adopted. The strength of correlation was determined by the correlation coefficient (r); analysis of covariance (ANOVA-Kruskal-Wallis test) was used to compare subgroups. Significance was set to p < 0.05., Results: One hundred thirty-one patients were included in the study, 71 females and 60 males. The Spearman correlation coefficient between the INCB-MG scale and the MGTS was 0.825 (p < 0.001), indicating a very strong correlation between them. Different items showed different correlations from low to high (0.32 to 0.80). As expected, correlation was lower between items with different evaluation modality (anamnestic vs clinical)., Discussion: The MGTS demonstrated a good correlation with INCB-MG, reliability and construct validity., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
3. Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports.
- Author
-
Frangiamore R, Giossi R, Vanoli F, Tourlaki A, Brambilla L, Maggi L, and Mantegazza R
- Subjects
- Humans, Iatrogenic Disease, Immunosuppression Therapy, Herpesvirus 8, Human, Myasthenia Gravis complications, Myasthenia Gravis drug therapy, Sarcoma, Kaposi
- Abstract
Introduction: Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompasses acetylcholinesterase inhibitors, oral steroids, and other immunosuppressants. Kaposi's sarcoma (KS) is a lymphangioproliferative disease associated with human herpesvirus 8 (HHV-8) infection and immunodeficiency or immunosuppression, mainly corticosteroids., Case Reports: We present two cases of MG patients treated with oral steroids who developed KS. Patient 1 was diagnosed with three oral KS lesions. Prednisone was discontinued with lesion regression and stabilization, while azathioprine and pyridostigmine prompted control of MG. Patient 2 developed KS lesions on the trunk and lower limbs while taking prednisone and azathioprine. Steroid tapering was started but new oral and lymph nodal lesions appeared. Paclitaxel therapy was introduced and the patient experienced pulmonary embolism and developed sensitive neuropathy. Complete remission of KS lesions was achieved and maintained with azathioprine and pyridostigmine as MG medications., Conclusions: KS is an uncommon but clinically relevant adverse event (AE) often induced by steroid therapy. It can be controlled by steroid withdrawal but could necessitate chemotherapy, which associates with further potential AEs. Skin evaluation should be performed in all patients with chronic steroid therapy. Steroid-sparing strategies, including new drugs, could reduce KS and other steroid-related comorbidities. HHV-8 testing should be considered before starting chronic immunosuppression.
- Published
- 2021
- Full Text
- View/download PDF
4. Multiple Sclerosis Questionnaire for Job Difficulties (MSQ-Job): definition of the cut-off score.
- Author
-
Schiavolin S, Giovannetti AM, Leonardi M, Brenna G, Brambilla L, Confalonieri P, Frangiamore R, Mantegazza R, Moscatelli M, Clerici VT, Cortese F, Covelli V, Ponzio M, Zaratin P, and Raggi A
- Subjects
- Adult, Analysis of Variance, Female, Humans, Male, Middle Aged, Quality of Life, ROC Curve, Multiple Sclerosis diagnosis, Multiple Sclerosis psychology, Surveys and Questionnaires, Work Performance
- Abstract
Multiple Sclerosis (MS) mainly affects people of working age. The Multiple Sclerosis Questionnaire for Job Difficulties (MSQ-Job) was designed to measure difficulties in work-related tasks. Our aim is to define cut-off score of MSQ-Job to identify potential critical situations that might require specific attention. A sample of patients with MS completed the MSQ-Job, WHODAS 2.0 and MSQOL-54 respectively for work difficulties, disability and health-related quality of life (HRQoL) evaluation. K-means Cluster Analysis was used to divide the sample in three groups on the basis of HRQoL and disability. ANOVA test was performed to compare the response pattern between these groups. The cut-off score was defined using the receiver operating characteristic (ROC) curve analyses for MSQ-Job total and count of MSQ-Job items scores ≥3: a score value corresponding to the maximum of the sensitivity-to-specificity ratio was chosen as the cut-off. Out of 180 patients enrolled, twenty were clustered in the higher severity group. The area under the ROC curve was 0.845 for the MSQ-Job total and 0.859 for the count of MSQ-Job items scores ≥3 while the cut-off score was 15.8 for MSQ-Job total and 8 for count of items scored ≥3. We recommend the use of MSQ-Job with this calculation as cut-off for identifying critical situations, e.g. in vocational rehabilitation services, where work-related difficulties have a significant impact in terms of lower quality of life and higher disability.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.